Global Cardiac Rehabilitation Market

Cardiac Rehabilitation Market Size, Share, Growth Analysis, By Device(Treadmill and Heart Rate Monitor), By End user(Hospitals and Clinics, and Home Care), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2185 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 60 | Figures: 75

Cardiac Rehabilitation Market Insights

Cardiac Rehabilitation Market size was valued at USD 2.07 Billion in 2022 and is poised to grow from USD 2.17 Billion in 2023 to USD 2.23 Billion by 2031, at a CAGR of 5.1% during the forecast period (2024-2031).

The global cardiac rehabilitation market is witnessing significant growth, driven by various factors that emphasise the importance of cardiac care and rehabilitation for patients with heart conditions. The market's growth is primarily attributed to the increasing prevalence of cardiovascular diseases (CVDs) worldwide, coupled with rising awareness about the benefits of cardiac rehabilitation programs. Governments and healthcare organisations are actively promoting these programs to reduce the burden of CVDs and improve patient outcomes. Furthermore, the growing geriatric population and sedentary lifestyles, which contribute to the rise in cardiovascular risk factors, are driving the demand for cardiac rehabilitation services.

Technological advancements in cardiac monitoring, exercise equipment, and telemedicine solutions are also propelling market growth by enhancing the efficiency and accessibility of cardiac rehabilitation programs. However, the market faces certain challenges, including the limited availability of cardiac rehabilitation facilities in some regions, especially in developing countries. Additionally, the high cost associated with comprehensive rehabilitation programs and the lack of reimbursement policies in some healthcare systems could hinder the adoption of cardiac rehabilitation services. Nonetheless, the increasing focus on preventive healthcare and the integration of advanced technologies are expected to drive the Global Cardiac Rehabilitation Market in the coming years, as stakeholders work towards providing accessible and effective cardiac care for patients worldwide.

US Cardiac Rehabilitation Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cardiac Rehabilitation Market size was valued at USD 2.07 Billion in 2022 and is poised to grow from USD 2.17 Billion in 2023 to USD 2.23 Billion by 2031, at a CAGR of 5.1% during the forecast period (2024-2031).

The global cardiac rehabilitation market features a highly competitive landscape with a multitude of healthcare providers, medical equipment manufacturers, and technology companies vying for market share. The competitive dynamics in the industry are primarily driven by the increasing demand for cardiac rehabilitation services due to the rising prevalence of cardiovascular diseases and growing awareness about the benefits of rehabilitation programs. Additionally, advancements in medical technology and the integration of telemedicine solutions have led to the entry of new players offering innovative cardiac rehabilitation services. Established healthcare institutions, hospitals, and specialty centres are key players in providing comprehensive cardiac rehabilitation programs, leveraging their expertise, infrastructure, and experienced medical staff. Medical equipment manufacturers play a critical role by supplying devices and equipment required for exercise training and patient monitoring during rehabilitation sessions. 'Philips Healthcare (Netherlands)', 'Johnson & Johnson (USA)', 'Amer Sports Corporation (Finland)', 'Smiths Group plc (UK)', 'Core Health & Fitness, LLC (USA)', 'OMRON Corporation (Japan)', 'Life Fitness, LLC (USA)', 'McKesson Corporation (USA)', 'Technogym S.p.A. (Italy)', 'Halma plc (UK)', 'AmeriCare Medical, Inc. (USA)', 'Brunswick Corporation (USA)', 'Ball Dynamics International, LLC (USA)', 'Ossur hf (Iceland)', 'Amedtec Medizintechnik Aue GmbH (Germany)', 'Bitmos GmbH (Germany)', 'Daavlin Company (USA)', 'Drive DeVilbiss Healthcare (USA)', 'Ergoline GmbH (Germany)', 'Medical Fitness Solutions (USA)'

The rising incidence of cardiovascular diseases, including heart attacks, coronary artery disease, and heart failure, is a significant driver for the global cardiac rehabilitation market. As CVDs become a leading cause of mortality and morbidity worldwide, the demand for cardiac rehabilitation programs grows to address the rehabilitation and recovery needs of patients.

Improved Accessibility: Telemedicine allows patients to participate in cardiac rehabilitation programs from the comfort of their homes or other convenient locations. This is particularly beneficial for patients living in remote areas with limited access to specialised cardiac rehabilitation centres.

North America stands as the dominant region in the global cardiac rehabilitation market. The region's dominance can be attributed to the well-developed healthcare infrastructure, strong emphasis on preventive healthcare, and the high prevalence of CVDs in countries like the United States and Canada. Additionally, favourable reimbursement policies and increased awareness about the benefits of cardiac rehabilitation programs among healthcare providers and patients contribute to the robust adoption of these services in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cardiac Rehabilitation Market

Report ID: SQMIG35D2185

$5,300
BUY NOW GET FREE SAMPLE